We have previously demonstrated that GRP-R is upregulated in poorly-differentiated neuroblastoma, promoting oncogenesis via activation of the PI3K/AKT signaling pathway, and plays an important role in the stabilization of the oncoprotein N-myc [22, 23]. This evidence concerns the gene MYCN and neuroblastoma.